Many patients in a geriatric clinic have cognitive deficits. Therefore the use of antidementia drugs there should be high. Moreover the situation might have changed over the past years. The study was done in a geriatric acute care and rehabilitation clinic with a big outpatient memory department. Most people come after falls or fractures, after surgery or with cardiovascular disease. The clinic orders the drugs through a central pharmacy which registers the number of pills delivered to the clinic. If possible the clinic usually continues prehospital medication. In 2017 1,239 patients were analyzed. The mean age was 82.4±7.1 years. The MMSE of these patients on admission was 24.7±4.8 points. On admission 46.4% had a MMSE of 27 to 30 points, 39.1% a MMSE of 20 to 26, 13.2% from 10 to 19 and only 1.4% a MMSE below 10 points. In 2017 516,745 pills were ordered through the central pharmacy, 1,612 of which were antidementia drugs. Therefore only 0.31% of all drugs used in 2017 were antidementia medication. The number even slightly decreased over the past years from 2,011 in 2007 to 1,692 in 2012 and finally to 1,612 in 2017. In 2017 donepezil was odered most often in 38.2% of the orders, rivastigmin in 19.9%, galantamine in 6.9%, memantine in 31.3% and others in 3.7%. This pattern had changed over the years. In 2007 rivastigmin was used in 72.9% of the orders, donepezil only in 12.2% and memantine in 9.0%. About 50% of the patients in the clinic had cognitive deficits with a MMSE of 26 points or lower. Despite that only 0.3% of the drugs ordered were antidementia drugs. This did not change much over the past 10 years or even decreased. Therefore antidementia medication seems to be not important in a geriatric clinic. The reasons for that are discussed.
Read full abstract